The Authors Reply.
作者信息
Sharma Shilpa, Hanudel Mark R, Ix Joachim H, Salusky Isidro B, Ganz Tomas, Nguyen Kim-Lien
机构信息
Division of Nephrology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Veterans Affairs, Greater Los Angeles Healthcare System, Los Angeles, California, USA.
出版信息
Kidney Int Rep. 2020 May 4;5(7):1119-1120. doi: 10.1016/j.ekir.2020.04.023. eCollection 2020 Jul.
Abstract
摘要
相似文献
1
The Authors Reply.作者回复。
Kidney Int Rep. 2020 May 4;5(7):1119-1120. doi: 10.1016/j.ekir.2020.04.023. eCollection 2020 Jul.
2
Aberrations of an IR chopping secondary: authors' reply to comment 2 and continuation of authors' reply to comment 1.红外斩波副镜的像差：作者对评论2的回复以及对评论1回复的延续
Appl Opt. 1985 Apr 1;24(7):944. doi: 10.1364/AO.24.000944.
3
Authors' reply: Comment on authors' reply: Patients' perception of risk: informed choice in prenatal testing for foetal aneuploidy.作者回复：对作者回复的评论：患者对风险的认知：胎儿非整倍体产前检测中的知情选择。
Singapore Med J. 2013 Apr;54(4):238. doi: 10.11622/smedj.2013084.
4
Letter: faecal calprotectin and lactoferrin - accurate biomarkers in post-operative Crohn's disease - authors' reply. Letter: biologic therapies are effective for prevention of post-operative Crohn's disease recurrence - authors' reply.信件：粪便钙卫蛋白和乳铁蛋白——克罗恩病术后的准确生物标志物——作者回复。信件：生物疗法对预防克罗恩病术后复发有效——作者回复。
Aliment Pharmacol Ther. 2014 Aug;40(3):323. doi: 10.1111/apt.12848.
5
Authors' Reply: In reply.作者回复：作为回复。
J Trauma Acute Care Surg. 2020 Dec;89(6):e191. doi: 10.1097/TA.0000000000002926.
6
Reply to Senefeld and Hunter: Physiology in Medicine: Neuromuscular consequences of diabetic neuropathy. The authors' reply.对塞内费尔德和亨特的回复：医学中的生理学：糖尿病性神经病变的神经肌肉后果。作者的回复。
J Appl Physiol (1985). 2016 Jul 1;121(1):361. doi: 10.1152/japplphysiol.00423.2016.
7
Reply to: Validation of database search strategies for the epidemiological study of pemphigus and pemphigoid: reply from the authors.回复：天疱疮和类天疱疮流行病学研究数据库检索策略的验证：作者的回复
Br J Dermatol. 2016 Mar;174(3):697. doi: 10.1111/bjd.14393. Epub 2016 Feb 16.
8
The Authors Reply: Reply on "Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients".作者回复：对“证据足够吗？：坦索罗辛0.2毫克和坦索罗辛0.4毫克作为亚洲良性前列腺增生患者初始治疗剂量疗效的系统评价和网络荟萃分析”的回复。
Int Neurourol J. 2017 Sep;21(3):231-232. doi: 10.5213/inj.1734986.493. Epub 2017 Sep 12.
9
Editorial: reply to delayed gastric emptying as an independent predictor of mortality in gastroparesis-it is clinically relevant after all! Authors' reply.社论：对胃轻瘫中延迟胃排空作为死亡率独立预测因素的回应——毕竟它具有临床相关性！作者的回应。
Aliment Pharmacol Ther. 2022 Apr;55(8):1048. doi: 10.1111/apt.16885.
10
Reply to: Comments on the authors' reply to the critical appraisal concerning "Wearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group study".回复：对作者对关于“用于预防心脏性猝死的可穿戴式心脏复律除颤器：一项卫生技术评估和患者焦点小组研究”的批判性评价的回复的评论
Med Devices (Auckl). 2019 Mar 22;12:129-131. doi: 10.2147/MDER.S202581. eCollection 2019.
本文引用的文献
1
Elevated Fibroblast Growth Factor 23 and Decreased Klotho Levels Are Associated With Diastolic Dysfunction in CKD G4-5D Patients.成纤维细胞生长因子23升高和klotho水平降低与CKD G4-5D患者的舒张功能障碍有关。
Kidney Int Rep. 2020 May 4;5(7):1118. doi: 10.1016/j.ekir.2020.04.022. eCollection 2020 Jul.
2
Elevated Fibroblast Growth Factor 23 Levels Are Associated With Greater Diastolic Dysfunction in ESRD.终末期肾病患者中，成纤维细胞生长因子23水平升高与更严重的舒张功能障碍相关。
Kidney Int Rep. 2019 Aug 9;4(12):1748-1751. doi: 10.1016/j.ekir.2019.07.022. eCollection 2019 Dec.
3
Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4.成纤维细胞生长因子 23 和 Klotho 与 CKD 2-4 期患者心血管结局的关系。
Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1049-58. doi: 10.2215/CJN.07870713. Epub 2014 Mar 27.
4
Validation of an immunoassay for soluble Klotho protein: decreased levels in diabetes and increased levels in chronic kidney disease.可溶性 Klotho 蛋白免疫测定法的验证：糖尿病患者水平降低，慢性肾脏病患者水平升高。
Am J Clin Pathol. 2012 Mar;137(3):479-85. doi: 10.1309/AJCPGPMAF7SFRBO4.
Zotero 插件